<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Monoallelic RUNX1 mutations cause familial <z:e sem="disease" ids="C0005818" disease_type="Disease or Syndrome" abbrv="">platelet disorder</z:e> with predisposition for <z:hpo ids='HP_0004808'>acute myelogenous leukemia</z:hpo> (FPD/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0003745'>Sporadic</z:hpo> mono- and biallelic mutations are found at high frequencies in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> M0, in radiation-associated and therapy-related <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>, and in <z:hpo ids='HP_0003745'>isolated cases</z:hpo> of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> M2, M5a, M3 relapse, and <z:hpo ids='HP_0005506'>chronic myelogenous leukemia</z:hpo> in <z:e sem="disease" ids="C0005699" disease_type="Neoplastic Process" abbrv="">blast phase</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Mutations in RUNX2 cause the inherited <z:e sem="disease" ids="C0263661" disease_type="Disease or Syndrome" abbrv="">skeletal disorder</z:e> cleidocranial <z:mpath ids='MPATH_589'>dysplasia</z:mpath> (CCD) </plain></SENT>
<SENT sid="3" pm="."><plain>Most hematopoietic missense mutations in Runx1 involve DNA-contacting residues in the <z:mp ids='MP_0001265'>Runt</z:mp> domain, whereas the majority of CCD mutations in Runx2 are predicted to impair CBFbeta binding or the <z:mp ids='MP_0001265'>Runt</z:mp> domain structure </plain></SENT>
<SENT sid="4" pm="."><plain>We introduced different classes of missense mutations into Runx1 and characterized their effects on DNA and CBFbeta binding by the <z:mp ids='MP_0001265'>Runt</z:mp> domain, and on Runx1 function in vivo </plain></SENT>
<SENT sid="5" pm="."><plain>Mutations involving DNA-contacting residues severely inactivate Runx1 function, whereas mutations that affect CBFbeta binding but not DNA binding result in hypomorphic alleles </plain></SENT>
<SENT sid="6" pm="."><plain>We conclude that hypomorphic RUNX2 alleles can cause CCD, whereas hematopoietic disease requires more severely inactivating RUNX1 mutations </plain></SENT>
</text></document>